VAERS reports by lot
Sanofi Pasteur DTaP/Tdap lot U7920AA: VAERS reports
20 VAERS reports list lot U7920AA as a Sanofi Pasteur DTaP/Tdap vaccine, received between 2023-11-10 and 2026-02-19. Data: VAERS public files through 28 May 2026 (site extract 2026-10-28).
Symptom categories in these reports
A report can mention several categories, so the counts add up to more than the number of reports.
| Category | Count | % |
|---|---|---|
| Neurological | 11 | 26% |
| Injection-site / Local reaction | 9 | 21% |
| Gastrointestinal | 7 | 17% |
| General / Systemic (non-local) | 7 | 17% |
| Musculoskeletal | 4 | 10% |
| Dermatological (non-injection-site) | 2 | 5% |
| Cardiac / Cardiovascular | 1 | 2% |
| Respiratory | 1 | 2% |
Where reports came from
U.S. state of the reporter, where given (top 10).
| State | Reports |
|---|---|
| Florida | 5 |
| New Mexico | 3 |
| Nebraska | 2 |
| New Jersey | 2 |
| Texas | 2 |
| North Dakota | 2 |
| Idaho | 1 |
| New York | 1 |
| Washington | 1 |
| California | 1 |
Reports by month received
| Month | Reports | Bar |
|---|---|---|
| 2023-11 | 2 | |
| 2023-12 | 4 | |
| 2024-01 | 1 | |
| 2024-02 | 3 | |
| 2024-04 | 3 | |
| 2024-06 | 1 | |
| 2024-08 | 1 | |
| 2025-05 | 1 | |
| 2025-11 | 1 | |
| 2026-01 | 1 | |
| 2026-02 | 2 |
Products recorded with this lot
- Td — Sanofi Pasteur (20 reports)
Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.
Related
- All Sanofi Pasteur DTaP/Tdap lots with VAERS reports
- DTaP/Tdap vaccine lot number lookup
- DTaP/Tdap vaccine side effects, trials and ingredients
- Daptacel: ingredients, package insert and side effects
- Look up a lot for any vaccine
Nearby Sanofi Pasteur DTaP/Tdap lots (A–Z): U7656AA · U7838AA · U7904AA · U7927AA · U7931AB · U7948BA
Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-10-28 18:08 UTC. Not medical advice. Report errors via contact.